Lv4
446 积分 2023-11-04 加入
Comparison of permitted daily exposure (PDE) values for active pharmaceutical ingredients (APIs) - Evidence of a robust approach
5天前
已完结
Deriving harmonised permitted daily exposures (PDEs) for paracetamol (acetaminophen) CAS #: 103-90-2
6天前
已完结
Iptacopan in IgA Nephropathy — Final 24-Month Data
28天前
已完结
Iptacopan in IgA Nephropathy — Final 24-Month Data
28天前
已完结
Addressing Disparity: Efficacy of Finerenone–Empagliflozin Combination in Asian Patients with Diabetic Kidney Disease
1个月前
已关闭
Finerenone in Type 1 Diabetes and Chronic Kidney Disease
1个月前
已完结
Next-generation therapeutics for diabetic kidney disease
1个月前
已完结
Hallmarks of cancer—Then and now, and beyond
1个月前
已完结
Meta-Analysis of Randomized Controlled Trials Assessing the Efficacy and Safety of Endothelin Receptor Antagonists in CKD
1个月前
已关闭
皖公网安备34019202002308